Oncostatin M induces angiogenesis in vitro and in vivo

Citation
M. Vasse et al., Oncostatin M induces angiogenesis in vitro and in vivo, ART THROM V, 19(8), 1999, pp. 1835-1842
Citations number
47
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN journal
10795642 → ACNP
Volume
19
Issue
8
Year of publication
1999
Pages
1835 - 1842
Database
ISI
SICI code
1079-5642(199908)19:8<1835:OMIAIV>2.0.ZU;2-M
Abstract
Neovascularization of the atherosclerotic plaque is responsible for its wea kening and consequently for the complications of vascular disease. Macropha ges are a source of growth factors that can modulate angiogenesis. In this study, we analyzed the effect of oncostatin M (OSM) on angiogenesis, as it could be involved in the development of atherosclerosis. The effect of OSM was compared with those of leukemia inhibitory factor (LLF) and interleukin -6 (IL-6). On human dermal microvasculature endothelial cells (HMEC-1s), OS M (22.5 to 112.5 pmol/L) induced a dose-dependent increase in cell prolifer ation greater than that induced by the classic angiogenic factors vascular endothelial growth factor (VEGF; 543 pmol/L:) and basic fibroblast growth f actor (bFGF; 1.1 nmol/L). LIF (19 to 475 pmol/L) induced only a 30% increas e in cell proliferation, and IL-6 had no effect. Furthermore, in a modified Boyden-chamber model, OSM, LIF, and IL-6 were chemoattractant for HMEC-1s. In a tridimensional gel of fibrin, OSM increased tube formation and tube l ength, which were already noticeable by day 3. LLF and IL-6 induced a weake r effect that was only obvious by day 10. The angiogenic effect of OSM was also demonstrated in vivo in a rabbit corneal model: OSM was more potent th an LIF, the length of the neovessels being longer with OSM than with LIF, w hereas IL-6 was without effect. We tested factors that could be involved in the proliferative effect of OSM on HMEC-1s. OSM induced only a slight incr ease in the urokinase receptor and a 60% increase in VEGF secretion, wherea s it does not modify IL-8 secretion or bFGF levels. The effect of OSM seems to depend on endothelial cell origin and cell species: OSM (up to 112.5 pm ol/L) did not induce human umbilical vein endothelial cell proliferation an d even had a small inhibitory effect (17%) on calf pulmonary artery endothe lial cells. In conclusion, OSM induces an angiogenic effect on capillary en dothelial cells, which could be, at least in part, implicated in pathologic al processes such as atherosclerosis or tumor growth.